EK-1

N/A

Report date: 2022/04/13 16:36:51
NME

Base Information

Drug NameEK-1
Drug Alias NameEK1EK-1
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCoronavirus spike glycoprotein inhibitorsviral membrane fusion inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShanxi Jinbo Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanxi Jinbo Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A